Efficacy and safety of antiseizure medication in post-stroke epilepsy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of antiseizure medication in post-stroke epilepsy
Authors
Keywords
-
Journal
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Volume 100, Issue -, Pages 109-114
Publisher
Elsevier BV
Online
2022-07-09
DOI
10.1016/j.seizure.2022.07.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy
- (2021) Simona Lattanzi et al. Brain Sciences
- Antiseizure medications for post‐stroke epilepsy: A real‐world prospective cohort study
- (2021) Tomotaka Tanaka et al. Brain and Behavior
- Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real‐world study "VOTE"
- (2021) Felix Rosenow et al. EPILEPSIA
- Lacosamide in patients with epilepsy of cerebrovascular etiology
- (2020) Felix Rosenow et al. ACTA NEUROLOGICA SCANDINAVICA
- Management of acute ischemic stroke
- (2020) Michael S Phipps et al. BMJ-British Medical Journal
- Eslicarbazepine acetate in post‐stroke epilepsy: Clinical practice evidence from Euro‐Esli
- (2020) Francisco Sales et al. ACTA NEUROLOGICA SCANDINAVICA
- Quality of Life and Resilience of Patients With Juvenile Stroke: A Systematic Review
- (2020) Lisa Bartholomé et al. Journal of Stroke & Cerebrovascular Diseases
- Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical practice study
- (2019) Florian Weissinger et al. EPILEPSY & BEHAVIOR
- Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?
- (2019) Zhi-mei Li et al. Current Medical Science
- Health-related quality of life in patients with poststroke epilepsy
- (2018) Yaroslav Winter et al. EPILEPSY & BEHAVIOR
- Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis
- (2018) F. Brigo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na+channel inactivation
- (2016) Dominik Holtkamp et al. EPILEPSIA
- Hypoxia/ischemia a key player in early post stroke seizures: Modulation by opioidergic and nitrergic systems
- (2015) Maziar Gooshe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide
- (2015) Simon Hebeisen et al. NEUROPHARMACOLOGY
- The pooled incidence of post-stroke seizure in 102 008 patients
- (2015) Safeng Zou et al. Topics in Stroke Rehabilitation
- Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study
- (2015) Tomotaka Tanaka et al. PLoS One
- Epilepsy in the elderly: comparing clinical characteristics with younger patients
- (2014) H. Stefan et al. ACTA NEUROLOGICA SCANDINAVICA
- Antiepileptogenesis in humans
- (2014) Eugen Trinka et al. CURRENT OPINION IN NEUROLOGY
- ILAE Official Report: A practical clinical definition of epilepsy
- (2014) Robert S. Fisher et al. EPILEPSIA
- Levetiracetam versus Carbamazepine in Patients with Late Poststroke Seizures: A Multicenter Prospective Randomized Open-Label Study (EpIC Project)
- (2012) D. Consoli et al. CEREBROVASCULAR DISEASES
- Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
- (2010) Massimo Mantegazza et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started